Vimarsana
Biggest News Aggregation in the World

Page 16 - Study Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Author Today - Breaking & Trending Today

Study highlights the economic burden of cardiovascular diseases in the European Union - Vimarsana News

Study highlights the economic burden of cardiovascular diseases in the European Union

Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at ESC Congress 2023.

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety - Vimarsana News

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction - Vimarsana News

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

Neighborhood conditions in early life can affect asthma risk in children - Vimarsana News

Neighborhood conditions in early life can affect asthma risk in children

Living in a neighborhood with better access to resources such as high-quality housing, healthy food, parks and playgrounds, and clean air during the early stages of childhood was associated with lower asthma incidence in a new study from NIH's Environmental influences on Child Health Outcomes (ECHO) Program.

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency - Vimarsana News

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalized patients with acute decompensated heart failure (ADHF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.